-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
NeuroBo Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2017 to Q2 2024.
- NeuroBo Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -109 %, a 149% decline year-over-year.
- NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2023 was -45.4 %, a 47.5% increase from 2022.
- NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2022 was -86.4 %, a 29.7% increase from 2021.
- NeuroBo Pharmaceuticals, Inc. annual Return On Assets for 2021 was -123 %, a 47% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)